Our Firm is representing a number of Xarelto lawsuit plaintiffs in U.S. courts, and we are looking forward to the multidistrict litigation’s Science Day.
New York, New York (PRWEB) April 16, 2015
Hundreds of Xarelto lawsuits (http://www.xareltolawsuit2015.com/) that allege the blood-thinning medication caused patients to experience uncontrollable internal bleeding and other dangerous complications continue to move forward in a federal multidistrict litigation underway in U.S. District Court, Eastern District of Louisiana. According to an Order dated April 7, 2015, the Court will convene a Science Day on June 11th at 9:00 a.m. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Our Firm is representing a number of Xarelto lawsuit plaintiffs in U.S. courts, and we are looking forward to the multidistrict litigation’s Science Day. The Science Day will serve to apprise the Court of scientific and medical issues that may prove relevant to our clients’ claims,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits in U.S. courts, and continues to evaluate claims on behalf of individuals who allegedly suffered a life-threatening internal bleeding episode, a stroke, deep vein thrombosis or pulmonary embolism due to their use of this blood thinner.
Court documents indicate that more than 300 Xarelto lawsuits have been filed in the multidistrict litigation underway in Louisiana, all of which allege that the drug’s manufacturers failed to provide adequate warnings regarding its association with serious side effects, including internal bleeding, strokes, deep vein thrombosis and pulmonary embolism. Among other things, plaintiffs cite allegedly misleading marketing claims which positioned Xarelto as a superior alternative to warfarin, a blood thinner that has been on the market for decades. The lawsuits point out that while internal bleeding associated with warfarin can be stopped via the administration of vitamin K, there is currently no approved antidote to reverse Xarelto bleeding.
In addition to the Xarelto lawsuits pending in the federal multidistrict litigation, at least 180 similar claims have been filed in a Pennsylvania mass tort litigation now underway in the Philadelphia Court of Common Pleas. (In Re: Xarelto Litigation, Case ID 150102349)
Individuals who allegedly experienced internal bleeding and other complications related to Xarelto may be entitled to compensation for the medical bills, lost wages, pain and suffering, and other damages. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP